7202
H. Malik et al. / Tetrahedron 66 (2010) 7198e7203
(50 mL) and LiOH$H2O (0.56 g, 13.7 mmol) was stirred for 16 h.
Then, THF was evaporated and 1 M HCl (50 mL) was added. The
product was extracted with EtOAc (2ꢂ100 mL). The organic layer
was dried (Na2SO4) and concentrated to obtain the free keto acid
derived from 18 as a white solid in 96% yield. Lactone 22 was
separated diastereomeric products (5a and 5b, 0.54 g, 80%). The
faster moving diastereomer was crystallized from CH2Cl2/n-hexane
to give GR24 (5a) as colourless crystals. The slower moving di-
astereomer was also crystallized from CH2Cl2/n-hexane to give
GR24 isomer 5b as colourless crystals. Analytical data were in
agreement with those reported in the literature.11
GR24 analogues 30a, 30b, 31a, 31b, 32a and 32b were prepared
by the same procedure.
prepared from the g-keto acid obtained above by reduction with
sodium borohydride followed by acid-catalyzed lactonization as
described by House et al. in 90% yield.12 Analytical data were in
agreement with those reported in the literature.12
Diastereomeric products 30a and 30b were obtained in 74%
overall yield.
Lactones 23e25 were prepared following the same procedure.
4.1.12. (ꢃ)-7,8-Dimethyl-3,3a,4,8b-tetrahydro-2H-indeno[1,2b]
4.1.17. (3aR
*
,8bS ,E)-7,8-Dimethyl-3-(((R)-4-methyl-5-oxo-2,5-dihy-
*
furan-2-one (23). Yield 87%, mp 74e74.5 ꢁC, FTIR (solid) cmꢀ1
:
drofuran-2-yl)oxymethylene)-3,3a,4,8b-tetrahydro-2H-indeno[1,2b]
1761, 1726. 1H NMR (300 MHz, CDCl3):
d
7.13 (d, 1H, J¼7.6 Hz), 6.98
furan-2-one (30a). Mp 180.8e181.2 ꢁC, FTIR (solid) cmꢀ1: 1778,
(d, 1H, J¼7.6 Hz), 5.94 (d, 1H, J¼6.9 Hz), 3.39e3.22 (m, 2H),
2.95e2.80 (m, 2H), 2.41 (dd, 1H, J¼17.7, 4.5 Hz), 2.33 (s, 3H), 2.27 (s,
1735, 1683. 1H NMR (300 MHz, CDCl3):
d
7.44 (d, 1H, J¼2.4 Hz), 7.12
(d, 1H, J¼7.8 Hz), 6.97e6.93 (m, 2H), 6.15e6.13 (m, 1H), 5.99 (d, 1H,
J¼8.1 Hz), 3.95e3.87 (m, 1H), 3.38 (dd, 1H, J¼16.5, 9.5 Hz), 3.03 (dd,
1H, J¼16.5, 3.6 Hz), 2.32 (s, 3H), 2.25 (s, 3H), 2.01 (t, 3H, J¼1.5 Hz).
3H). 13C NMR (75 MHz, CDCl3):
d 176.6 (s), 139.8 (s), 137.2 (s), 135.3
(s), 134.6 (s), 131.3 (d), 121.7 (d), 87.0 (d), 37.6 (t), 36.6 (t), 35.5 (d),
18.9 (q), 15.1 (q). HRMS (ESI) m/z calcd for C13H14O2 (MþNa)þ:
225.08915, found: 225.08829.
13C NMR (75 MHz, CDCl3):
d 171.0 (s), 169.8 (s), 150.3 (d), 140.6 (d),
139.7 (s), 137.3 (s), 135.3 (s), 135.2 (s), 134.7 (s), 131.4 (d), 121.5 (d),
113.2 (s), 100.1 (d), 85.4 (d), 38.2 (t), 37.0 (d), 19.1 (q), 15.2 (q), 10.2
(q). HRMS (ESI) m/z calcd for C19H18O5 (MþNa)þ: 349.10519, found:
349.10476.
4.1.13. (ꢃ)-6,7-Dimethyl-3,3a,4,8b-tetrahydro-2H-indeno[1,2b]
furan-2-one (24). Yield 88%, mp 98e98.5 ꢁC, FTIR (solid) cmꢀ1
:
1718, 1696. 1H NMR (300 MHz, CDCl3):
d 7.24 (s, 1H), 7.04 (s, 1H),
5.83 (d, 1H, J¼6.9 Hz), 3.39e3.19 (m, 2H), 2.92e2.77 (m, 2H), 2.36
4.1.18. (3aR
hydrofuran-2-yl)oxymethylene)-3,3a,4,8b-tetrahydro-2H-indeno
[1,2b]furan-2-one (30b). Mp 190.9e191.4 ꢁC, FTIR (solid) cmꢀ1
1778,1739,1679. 1H NMR (300 MHz, CDCl3):
*
,8bS
*
,E)-7,8-Dimethyl-3-(((S
*
)-4-methyl-5-oxo-2,5-di-
(dd, 1H, J¼15.6, 5.4 Hz), 2.26 (s, 6H). 13C NMR (75 MHz, CDCl3):
d
176.5 (s), 139.5 (s), 138.3 (s), 135.9 (s), 135.6 (s), 126.5 (d), 125.7 (d),
:
87.3 (d), 37.1 (2ꢂt), 35.3 (d), 19.5 (q), 19.2 (q). HRMS (ESI) m/z calcd
d
7.46 (d,1H, J¼2.7 Hz),
for C13H14O2 (MþNa)þ: 225.08915, found: 225.08965.
7.11 (d, 1H, J¼7.5 Hz), 6.97e6.93 (m, 2H), 6.18e6.16 (m, 1H), 6.00 (d,
1H, J¼7.8 Hz), 3.95e3.87 (m, 1H), 3.38 (dd, 1H, J¼16.8, 9.6 Hz), 3.02
(dd, 1H, J¼16.8, 3.6 Hz), 2.33 (s, 3H), 2.25 (s, 3H), 2.02 (t, 3H,
4.1.14. (ꢃ)-5,8-Dimethyl-3,3a,4,8b-tetrahydro-2H-indeno[1,2b]
furan-2-one (25). Yield 84%, mp 87.2e87.7 ꢁC, FTIR (solid) cmꢀ1
:
J¼1.5 Hz). 13C NMR (75 MHz, CDCl3):
d 171.0 (s), 169.8 (s), 150.2 (d),
1752, 1692. 1H NMR (300 MHz, CDCl3):
d
7.06 (d, 1H, J¼7.5 Hz), 6.99
140.6 (d), 139.8 (s), 137.2 (s), 135.3 (s), 135.1 (s), 134.6 (s), 131.4 (d),
121.6 (d), 113.3 (s), 100.1 (d), 85.4 (d), 38.2 (t), 37.1 (d), 18.8 (q), 15.2
(q), 10.2 (q). HRMS (ESI) m/z calcd for C19H18O5 (MþNa)þ:
349.10519, found: 349.10543.
(d, 1H, J¼7.5 Hz), 5.95 (d, 1H, J¼7.2 Hz), 3.41e3.31 (m, 1H),
3.29e3.18 (m, 1H), 2.98e2.89 (m, 1H), 2.77 (dd, 1H, J¼16.5, 4.5 Hz),
2.44 (dd, 1H, J¼16.5, 4.5 Hz), 2.38 (s, 3H), 2.21 (s, 3H). 13C NMR
(75 MHz, CDCl3):
d
179.4 (s), 141.1 (s), 136.6 (s), 133.4 (s), 131.2 (s),
Diastereomeric products 31a and 31b were obtained in 76%
overall yield.
130.3 (d), 128.3 (d), 87.2 (d), 36.9 (t), 36.0 (t), 35.6 (d), 18.3 (q), 17.6
(q). HRMS (ESI) m/z calcd for C13H14O2 (MþNa)þ: 225.08915, found:
225.08896.
4.1.19. (3aR
hydrofuran-2-yl)oxymethylene)-3,3a,4,8b-tetrahydro-2H-indeno
[1,2b]furan-2-one (31a). Mp 233.8e234.3 ꢁC, FTIR (solid) cmꢀ1
1787, 1726, 1679. 1H NMR (300 MHz, CDCl3):
*
,8bS
*
,E)-6,7-Dimethyl-3-(((R
*
)-4-methyl-5-oxo-2,5-di-
4.1.15. 5-Bromo-3-methylfuran-2(5H)-one (8). To 3-methylfuran-2
(5H)-one (0.20 g, 2.06 mmol) in dry CCl4 (20 mL) was added NBS
(0.40 g, 2.26 mmol) and AIBN (5 mg) and the resulting reaction
mixture was heated at reflux for 2 h while irradiating with a 250 W
lamp. The mixture was cooled to 0 ꢁC and the solid succinimide was
filtered off. The solvent was removed in vacuo to give bromobute-
nolide 8, which was used as such in the coupling step.
:
d
7.43 (d, 1H, J¼2.7 Hz),
7.24 (s, 1H), 6.99 (s, 1H), 6.95 (t, 1H, J¼1.5 Hz), 6.12 (t, 1H, J¼1.5 Hz),
5.87 (d, 1H, J¼7.5 Hz), 3.93e3.85 (m, 1H), 3.34 (dd, 1H, J¼16.8,
9.3 Hz), 3.01 (dd, 1H, J¼16.8, 3.1 Hz), 2.24 (s, 6H), 2.01 (t, 3H,
J¼1.5 Hz). 13C NMR (75 MHz, CDCl3):
d 170.9 (s), 169.8 (s), 150.4 (d),
140.6 (d), 139.6 (s), 138.4 (s), 136.05 (s), 135.60 (s), 135.36 (s), 126.58
(d), 125.49 (d), 113.04 (s), 100.1 (d), 85.5 (d), 38.7 (t), 36.5 (d), 19.5
(q), 19.2 (q), 10.2 (q). HRMS (ESI) m/z calcd for C19H18O5 (MþNa)þ:
349.10519, found: 349.10503.
4.1.16. (3aR
yl)oxymethylene)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one
5a and its 20S
diastereomer 5b. Potassium tert-butoxide (0.31 g,
*
,8bS
*
,E)-3-(((R
*
)-4-Methyl-5-oxo-2,5-dihydrofuran-2-
*
2.75 mmol) was added in small portions to a solution of lactone 22
(0.40 g, 2.29 mmol) and methyl formate (0.30 mL, 3.44 mmol) in
anhydrous THF (10 mL, freshly distilled) with stirring at 0 ꢁC under
nitrogen. Stirring was continued at room temperature until all
lactone had reacted (monitored by TLC, EtOAc/n-heptane 3:7). THF
was removed in vacuo. The resulting salt was used as such in the
coupling with bromobutenolide 8.
To a solution of formylated product 26 in DME (10 mL) under
nitrogen was added a solution of bromobutenolide 8 in DME (5 mL).
The reaction mixture was stirred overnight, DME was evaporated,
diluted with water (15 mL) and extracted with EtOAc (3ꢂ20 mL).
The organic layer was dried (Na2SO4) and concentrated. The
resulting diastereomeric mixture was purified by flash chroma-
tography (SiO2, EtOAc/n-heptane 1:1) to afford two partly
4.1.20. (3aR
hydrofuran-2-yl)oxymethylene)-3,3a,4,8b-tetrahydro-2H-indeno
[1,2b]furan-2-one (31b). Mp 195.4e195.9 ꢁC, FTIR (solid) cmꢀ1
1769, 1748, 1674. 1H NMR (300 MHz, CDCl3):
*
,8bS
*
,E)-6,7-Dimethyl-3-(((S )-4-methyl-5-oxo-2,5-di-
*
:
d
7.45 (d, 1H, J¼2.4 Hz),
7.24 (s, 1H), 6.99 (s, 1H), 6.96e6.94 (m, 1H), 6.18e6.16 (m, 1H), 5.88
(d, 1H, J¼7.8 Hz), 3.93e3.85 (m, 1H), 3.33 (dd, 1H, J¼16.8, 9.3 Hz),
3.00 (dd, 1H, J¼16.8, 3.3 Hz), 2.24 (s, 6H), 2.02 (t, 3H, J¼1.5 Hz). 13C
NMR (75 MHz, CDCl3): d 170.9 (s), 169.8 (s), 150.4 (d), 140.6 (d),
139.7 (s), 138.4 (s), 135.9 (s), 135.5 (s), 135.3 (s), 126.5 (d), 125.5 (d),
113.1 (s), 100.2 (d), 85.5 (d), 38.6 (t), 36.5 (d), 19.5 (q), 19.2 (q), 10.2
(q). HRMS (ESI) m/z calcd for C19H18O5 (MþNa)þ: 349.10519, found:
349.10511.
Diastereomeric products 32a and 32b were obtained in 73%
overall yield.